Oncolytics Biotech Stock In The News

ONCY Stock  USD 0.94  0.01  1.05%   
Our overall analysis of Oncolytics Biotech's news coverage and content from conventional and social sources shows investors' bearish mood towards Oncolytics Biotech. The specific impact of Oncolytics Biotech news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Oncolytics Biotech's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Oncolytics Biotech headlines in addition to utilizing other, more conventional financial analysis modules. Check out Oncolytics Biotech Backtesting and Oncolytics Biotech Hype Analysis.
For more information on how to buy Oncolytics Stock please use our How to Invest in Oncolytics Biotech guide.

Oncolytics Biotech Today Top News and Investor Outlook

Yahoo News
3 Under-$20 Stocks to Buy for Explosive Returns
https://finance.yahoo.com/news/3-under-20-stocks-buy-110051440.html
 Bullish
Yahoo News
Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 43rd Annual Growth Conference
https://finance.yahoo.com/news/oncolytics-biotech-participate-fireside-chat-110500803.html
 Neutral
Yahoo News
Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights
https://finance.yahoo.com/news/oncolytics-biotech-host-conference-call-110000313.html
 Neutral
Yahoo News
Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights
https://finance.yahoo.com/news/oncolytics-biotech-host-conference-call-110000661.html
 Neutral
Yahoo News
Oncolytics Biotech® Announces US$15 Million Bought Deal Offering of Units
https://finance.yahoo.com/news/oncolytics-biotech-announces-us-15-105500960.html
 Neutral
Yahoo News
Oncolytics Biotech's® Pelareorep Selected for Inclusion in Precision PromiseSM Pivotal Phase 3 Platform Trial
https://finance.yahoo.com/news/oncolytics-biotechs-pelareorep-selected-inclusion-110000401.html
 Neutral
Yahoo News
Oncolytics Biotech® Announces Updated Ra...
https://finance.yahoo.com/news/oncolytics-biotech-announces-updated-randomized-110000938.html
 Neutral
Yahoo News
Oncolytics Biotech® to Host Key Opinion ...
https://finance.yahoo.com/news/oncolytics-biotech-host-key-opinion-153000241.html
 Neutral
Yahoo News
Oncolytics Biotech® Announces Positive R...
https://finance.yahoo.com/news/oncolytics-biotech-announces-positive-randomized-214100627.html
 Neutral
Yahoo News
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
https://finance.yahoo.com/news/oncolytics-biotech-announces-voting-results-110000283.html
 Bullish

Oncolytics Biotech Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Oncolytics and other traded companies coverage with news coverage. We help investors stay connected with Oncolytics headlines for the 26th of November to make an informed investment decision based on correlating the impacts of news items on Oncolytics Stock performance. Please note that trading solely based on the Oncolytics Biotech hype is not for everyone as timely availability and quick action are needed to avoid losses.
Oncolytics Biotech's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Oncolytics Biotech investors visualize upcoming and past events in order to time the market based on Oncolytics Biotech noise-free hype analysis.
Oncolytics Biotech stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Oncolytics earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Oncolytics Biotech that are available to investors today. That information is available publicly through Oncolytics media outlets and privately through word of mouth or via Oncolytics internal channels. However, regardless of the origin, that massive amount of Oncolytics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Oncolytics Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Oncolytics Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Oncolytics Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Oncolytics Biotech alpha.

Oncolytics Largest EPS Surprises

Earnings surprises can significantly impact Oncolytics Biotech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-09
2024-03-31-0.11-0.090.0218 
2022-08-11
2022-06-30-0.11-0.090.0218 
2020-11-11
2020-09-30-0.14-0.16-0.0214 
2024-11-04
2024-09-30-0.07-0.0908-0.020829 
2023-05-05
2023-03-31-0.13-0.10.0323 
2022-11-07
2022-09-30-0.11-0.080.0327 
View All Earnings Estimates

Oncolytics Biotech Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Oncolytics Biotech Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
insidermonkey News
15th of November 2024
Oncolytics Biotech Inc. Q3 2024 Earnings Call Transcript
at insidermonkey.com 
Gurufocus Stories at Macroaxis
13th of November 2024
Oncolytics Biotech Inc Q3 2024 Earnings Call Highlights Strategic Advances and ...
at gurufocus.com 
news
14th of October 2024
Oncolytic Virus Therapy Market Set to Witness Significant Growth by 2024-2031Oncolytics Bi...
at kalkinemedia.com 
Yahoo News
4th of October 2024
Oncolytics Biotech Announces Key Progress and Upcoming Studies for Breast and Pancreatic C...
at finance.yahoo.com 
news
23rd of September 2024
Oncolytics Biotechs Buy Rating Reaffirmed at HC Wainwright
at thelincolnianonline.com 
Yahoo News
6th of September 2024
Oncolytics Biotech to Participate in Fireside Chats at Two Investment Conferences in Septe...
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Oncolytics Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Oncolytics Biotech's short interest history, or implied volatility extrapolated from Oncolytics Biotech options trading.

Additional Tools for Oncolytics Stock Analysis

When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.